GlaxoSmithKline plc Company Profile (LON:GSK)

About GlaxoSmithKline plc (LON:GSK)

GlaxoSmithKline plc logoGlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines, vaccines and consumer healthcare products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. The Consumer Healthcare business develops and markets products in Wellness, Oral health, Nutrition and Skin health categories. Its product portfolio includes Adartrel, Bexsero, Daraprim and Quinvaxem. Its brands include Panadol, abreva, polident and physiogel.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Pharmaceuticals
  • Sub-Industry: N/A
  • Symbol: LON:GSK
  • CUSIP: N/A
  • Web:
  • Market Cap: £74.47 billion
  • Outstanding Shares: 4,888,000,000
Average Prices:
  • 50 Day Moving Avg: GBX 1,502.15
  • 200 Day Moving Avg: GBX 1,580.48
  • 52 Week Range: GBX 1,444 - GBX 1,724.50
  • Trailing P/E Ratio: 38.96
  • P/E Growth: 2.40
Sales & Book Value:
  • Annual Revenue: £29.83 billion
  • Price / Sales: 2.50
  • Book Value: GBX 0.17 per share
  • Price / Book: 89.62
  • Dividend Yield: 5.1%
  • EBITDA: £8.15 billion
  • Net Margins: -1.17%
  • Return on Equity: -57.19%
  • Return on Assets: -0.59%
  • Average Volume: 7.98 million shs.

Frequently Asked Questions for GlaxoSmithKline plc (LON:GSK)

What is GlaxoSmithKline plc's stock symbol?

GlaxoSmithKline plc trades on the London Stock Exchange (LON) under the ticker symbol "GSK."

How often does GlaxoSmithKline plc pay dividends? What is the dividend yield for GlaxoSmithKline plc?

GlaxoSmithKline plc announced a dividend on Wednesday, July 26th. Stockholders of record on Thursday, August 10th will be given a dividend of GBX 19 per share on Thursday, October 12th. This represents a dividend yield of 1.23%. The ex-dividend date is Thursday, August 10th. The official announcement can be accessed at this link. View GlaxoSmithKline plc's Dividend History.

Where is GlaxoSmithKline plc's stock going? Where will GlaxoSmithKline plc's stock price be in 2017?

20 analysts have issued 12 month price targets for GlaxoSmithKline plc's stock. Their forecasts range from GBX 1,300 to GBX 2,000. On average, they anticipate GlaxoSmithKline plc's stock price to reach GBX 1,690.53 in the next year. View Analyst Ratings for GlaxoSmithKline plc.

Who are some of GlaxoSmithKline plc's key competitors?

Who are GlaxoSmithKline plc's key executives?

GlaxoSmithKline plc's management team includes the folowing people:

  • Emma Walmsley, Chief Executive Officer, Executive Director
  • Simon Dingemans, Chief Financial Officer, Executive Director
  • Patrick Vallance, President - R&D, Executive Director
  • Roger Connor, President - Global Manufacturing & Supply
  • Luc Debruyne, President - Global Vaccines
  • Abbas Hussain, President - Global Pharmaceuticals
  • Shah Abbas Hussain, President - Global Pharmaceuticals
  • Brian McNamara, Chief Executive Officer - GSK Consumer Healthcare
  • Luke Miels, President - Global Pharmaceuticals
  • Daniel E. Troy, Senior Vice President, General Counsel

How do I buy GlaxoSmithKline plc stock?

Shares of GlaxoSmithKline plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is GlaxoSmithKline plc's stock price today?

One share of GlaxoSmithKline plc stock can currently be purchased for approximately GBX 1,523.50.

MarketBeat Community Rating for GlaxoSmithKline plc (LON GSK)
Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  487 (Vote Outperform)
Underperform Votes:  1,169 (Vote Underperform)
Total Votes:  1,656
MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for GlaxoSmithKline plc (LON:GSK) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Sell Ratings, 9 Hold Ratings, 7 Buy Ratings
Consensus Rating:Hold (Score: 2.15)
Consensus Price Target: GBX 1,690.53
Consensus Price Target History for GlaxoSmithKline plc (LON:GSK)
Price Target History for GlaxoSmithKline plc (LON:GSK)
Analysts' Ratings History for GlaxoSmithKline plc (LON:GSK)
DateFirmActionRatingPrice TargetDetails
10/18/2017Morgan StanleySet Price TargetSellGBX 1,600View Rating Details
10/17/2017Goldman Sachs Group, Inc. (The)Reiterated RatingBuyGBX 1,900View Rating Details
10/16/2017Jefferies Group LLCBoost Price TargetBuyGBX 1,675 -> GBX 1,700View Rating Details
10/12/2017Deutsche Bank AGSet Price TargetNeutralGBX 1,610View Rating Details
10/4/2017Liberum CapitalLower Price TargetBuyGBX 1,900 -> GBX 1,760View Rating Details
10/2/2017J P Morgan Chase & CoReiterated RatingNeutralGBX 1,570View Rating Details
9/20/2017Shore CapitalReiterated RatingHoldView Rating Details
9/19/2017Berenberg BankReiterated RatingBuyGBX 1,835View Rating Details
9/19/2017Bryan, Garnier & CoReiterated RatingNeutralGBX 1,710View Rating Details
9/13/2017HSBC Holdings plcReiterated RatingBuyGBX 1,970View Rating Details
9/8/2017Citigroup Inc.Reiterated RatingNeutralGBX 1,700View Rating Details
9/6/2017BNP ParibasSet Price TargetNeutralGBX 1,620View Rating Details
9/6/2017Credit Suisse GroupLower Price TargetNeutralGBX 1,775 -> GBX 1,725View Rating Details
7/27/2017Kepler Capital MarketsReiterated RatingReduceGBX 1,520View Rating Details
7/27/2017Barclays PLCReiterated RatingEqual weightGBX 1,550View Rating Details
7/26/2017S&P GlobalSet Price TargetSellGBX 1,500View Rating Details
7/26/2017InvestecReiterated RatingBuyGBX 1,800View Rating Details
6/1/2017Beaufort SecuritiesBoost Price TargetBuyGBX 1,750 -> GBX 2,000View Rating Details
3/23/2017Societe GeneraleReiterated RatingSellGBX 1,300View Rating Details
10/27/2016NatixisReiterated RatingNeutralGBX 1,750View Rating Details
10/19/2016Sanford C. BernsteinSet Price TargetNeutralGBX 1,834View Rating Details
8/4/2016Independent Research GmbHSet Price TargetNeutralGBX 1,800View Rating Details
7/27/2016S&P Global Inc.Set Price TargetNeutralGBX 1,650View Rating Details
7/7/2016Canaccord GenuityReiterated RatingHoldGBX 1,785View Rating Details
3/10/2016AlphaValueReiterated RatingAddGBX 1,536View Rating Details
2/12/2016Baader BankReiterated RatingHoldGBX 1,530View Rating Details
1/28/2016Leerink SwannReiterated RatingMarket PerformGBX 1,565View Rating Details
11/17/2015JP Morgan CazenoveReiterated RatingNeutralGBX 1,370View Rating Details
11/6/2015Oddo SecuritiesReiterated RatingReduceGBX 1,360View Rating Details
(Data available from 10/22/2015 forward)


Earnings History for GlaxoSmithKline plc (LON:GSK)
No earnings announcements for this company have been tracked by


Earnings Estimates for GlaxoSmithKline plc (LON:GSK)
Current Year EPS Consensus Estimate: $110.55 EPS


Dividend History by Quarter for GlaxoSmithKline plc (LON GSK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/26/2017GBX 191.23%8/10/20178/10/201710/12/2017
4/26/2017GBX 191.21%5/11/20175/11/20177/13/2017
2/8/2017GBX 231.47%2/23/20172/23/20174/13/2017
10/26/2016GBX 191.17%11/3/201611/3/20161/12/2017
7/27/2016GBX 191.12%8/11/20168/11/201610/13/2016
4/27/2016GBX 191.28%5/12/20165/12/20167/14/2016
10/28/2015GBX 191.34%11/12/201511/12/20151/14/2016
10/28/2015GBX 201.34%2/18/20162/18/20164/14/2016
7/29/2015GBX 191.38%8/13/20158/13/201510/1/2015
5/6/2015GBX 191.25%5/14/20155/14/20157/9/2015
2/4/2015GBX 231.56%2/19/20152/19/20154/9/2015
10/22/2014GBX 191.37%11/6/201411/6/20141/8/2015
7/23/2014GBX 191.28%8/6/20148/6/201410/2/2014
4/30/2014GBX 191.17%5/14/20145/14/20147/10/2014
2/5/2014GBX 231.36%2/19/20142/19/20144/10/2014
10/23/2013GBX 191.15%11/13/201311/13/20131/9/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for GlaxoSmithKline plc (LON:GSK)
Insider Trades by Quarter for GlaxoSmithKline plc (LON:GSK)
Insider Trades by Quarter for GlaxoSmithKline plc (LON:GSK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/12/2017Simon DingemansInsiderBuy1,076GBX 1,527£16,430.52
10/10/2017Victoria WhyteInsiderBuy9GBX 1,518£136.62
9/11/2017Dominic RedfernInsiderBuy8GBX 1,501£120.08
8/9/2017Dominic RedfernInsiderBuy8GBX 1,519£121.52
7/26/2017Manvinder Singh BangaInsiderBuy2,267GBX 1,599£36,249.33
7/14/2017Patrick VallanceInsiderBuy861GBX 1,618£13,930.98
7/11/2017Victoria WhyteInsiderBuy8GBX 1,604£128.32
6/20/2017Victoria WhyteInsiderSell4,820GBX 1,693£81,602.60
6/9/2017Simon DingemansInsiderBuy7GBX 1,701£119.07
5/10/2017Patrick VallanceInsiderBuy7GBX 1,615£113.05
4/26/2017Vivienne CoxInsiderBuy335GBX 1,583£5,303.05
4/18/2017Emma WalmsleyInsiderBuy83GBX 1,647£1,367.01
4/13/2017Dominic RedfernInsiderBuy230GBX 1,639£3,769.70
3/9/2017Sir Andrew P WittyInsiderBuy7GBX 1,673£117.11
3/7/2017Moncef SlaouiInsiderBuy56GBX 2,072£1,160.32
2/22/2017Simon DingemansInsiderSell3,589GBX 1,640£58,859.60
2/20/2017Sir Andrew P WittyInsiderSell10,633GBX 1,634£173,743.22
2/16/2017Patrick VallanceInsiderSell32,996GBX 1,624£535,855.04
2/9/2017Victoria WhyteInsiderSell4,820GBX 1,576£75,963.20
2/8/2017Vivienne CoxInsiderBuy342GBX 1,555£5,318.10
1/11/2017Simon DingemansInsiderBuy8GBX 1,596£127.68
1/9/2017Moncef SlaouiInsiderBuy58GBX 1,972£1,143.76
12/9/2016Sir Andrew P WittyInsiderBuy8GBX 1,478£118.24
11/9/2016Victoria WhyteInsiderBuy8GBX 1,593£127.44
11/3/2016Moncef SlaouiInsiderBuy6GBX 1,937£116.22
10/27/2016Sir Andrew P WittyInsiderSell10,000GBX 1,636£163,600
10/26/2016Manvinder Singh BangaInsiderBuy1,750GBX 1,643£28,752.50
10/11/2016Simon DingemansInsiderBuy7GBX 1,728£120.96
10/7/2016Moncef SlaouiInsiderBuy4GBX 2,148GBX 8,592
9/22/2016Moncef SlaouiInsiderBuy2GBX 2,179GBX 4,358
9/9/2016Witty,Sir Andrew PInsiderBuy8GBX 1,616£129.28
8/12/2016Slaoui,MoncefInsiderBuy28GBX 2,208£618.24
8/9/2016Dingemans,SimonInsiderBuy8GBX 1,680£134.40
7/27/2016Witty,Sir Andrew PInsiderSell10,000GBX 1,693£169,300
7/11/2016Witty,Sir Andrew PInsiderBuy7GBX 1,671£116.97
7/8/2016Slaoui,MoncefInsiderBuy4GBX 2,169GBX 8,676
7/1/2016Cartwright,StaceyInsiderBuy461GBX 1,559£7,186.99
6/9/2016Dingemans,SimonInsiderBuy9GBX 1,441£129.69
5/20/2016Slaoui,MoncefInsiderBuy14GBX 2,100£294
5/12/2016Slaoui,MoncefInsiderBuy24GBX 2,103£504.72
5/11/2016Witty,Sir Andrew PInsiderBuy8GBX 1,476£118.08
4/28/2016Witty,Sir Andrew PInsiderSell10,000GBX 1,475£147,500
4/14/2016Slaoui,MoncefInsiderBuy495GBX 2,156£10,672.20
3/31/2016Anderson,Sir RoyInsiderBuy511GBX 1,405£7,179.55
3/9/2016Witty,Sir Andrew PInsiderBuy9GBX 1,404£126.36
2/15/2016Dingemans,SimonInsiderSell39,987GBX 1,406£562,217.22
2/9/2016Witty,Sir Andrew PInsiderBuy9GBX 1,369£123.21
1/28/2016Dingemans,SimonInsiderBuy684GBX 1,381£9,446.04
1/14/2016Witty,Sir Andrew PInsiderBuy43GBX 1,369£588.67
1/12/2016Dingemans,SimonInsiderBuy9GBX 1,359£122.31
12/9/2015Dingemans,SimonInsiderBuy9GBX 1,325£119.25
11/10/2015Dingemans,SimonInsiderBuy9GBX 1,366£122.94
10/12/2015Dingemans,SimonInsiderBuy10GBX 1,307£130.70
10/1/2015Rohner,UrsInsiderBuy525GBX 1,251£6,567.75
9/10/2015Witty,Sir Andrew PInsiderBuy10GBX 1,318£131.80
8/12/2015Dingemans,SimonInsiderBuy8GBX 1,443£115.44
7/10/2015Witty,Sir Andrew PInsiderBuy9GBX 1,369£123.21
7/1/2015Wijers,HansInsiderBuy534GBX 13.45GBX 7,182.30
3/31/2015Sir Christopher GentInsiderBuy3,991GBX 1,566£62,499.06
3/9/2015Moncef SlaouiInsiderSell22,274GBX 1,544£343,910.56
2/18/2015Moncef SlaouiInsiderSell1,580GBX 1,553£24,537.40
2/13/2015Simon DingemansInsiderSell12,605GBX 1,543.12£194,510.28
(Data available from 1/1/2013 forward)


Headline Trends for GlaxoSmithKline plc (LON:GSK)
Latest Headlines for GlaxoSmithKline plc (LON:GSK)
Loading headlines, please wait.


Social activity is not available for this stock.


GlaxoSmithKline plc (GSK) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.